Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anurag Kumar

Showing results (241-250 of 300) with videos related to

Pageof 30
Sort By:
Molecular Biology Reports|June 28, 2023
Development and validation of most efficient RNA isolation method from buffalo bull spermatozoaRashi Vasisth, Ankita Gurao, Namita Kumari, et al.
Mini Reviews in Medicinal Chemistry|December 3, 2021
A Comprehensive Review on PCSK9 as Mechanistic Target Approach in Cancer TherapyAmita Singh, Pranesh Kumar, Archana Bharti Sonkar, et al.
Parasites & Vectors|December 5, 2024
Monitoring alpha-cypermethrin susceptibility of Phlebotomus argentipes, the vector of visceral leishmaniasis in India, using the CDC bottle bioassayRahul Chaubey, Ashish Shukla, Anurag Kumar Kushwaha, et al.
Functional & Integrative Genomics|December 26, 2025
Genome Editing Enhanced Abiotic Stress ToleranceIn Cereal CropsShambhu Krishan Lal, Gullnaj Khatoon, Anurag Kumar, et al.
International Journal of Biological Macromolecules|February 17, 2020
Tyr320 is a molecular determinant of the catalytic activity of β-glucosidase from Neosartorya fischeriRamasamy Shanmugam, In-Won Kim, Manish K Tiwari, et al.
AACE Endocrinology and Diabetes|April 6, 2026
Uncovering the Predictors of Nonadherence to Insulin Therapy Among Patients With Type 1 and Type 2 Diabetes Attending an Endocrinology Outpatient Clinic of a Tertiary Care HospitalSourav Debnath, Sanjeet Purohit, Anurag Kumar Singh, et al.
Pharmaceutics|May 4, 2026
Correction: Kumar et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. <i>Pharmaceutics</i> 2024, <i>16</i>, 913Rohit Kumar, Anurag Kumar, Dharmendra Kumar, et al.
Frontiers in Oncology|February 13, 2026
Correction: Epidemiological profile of patients with malignant neoplasm admitted to a tertiary care center in India: a retrospective cross-sectional studySourav Debnath, Pusparghya Pal, Anurag Kumar Singh, et al.
Msystems|January 8, 2026
Characterizing ceftriaxone tolerance in <i>Neisseria gonorrhoeae</i> across <i>in vitro</i> and <i>in vivo</i> modelsIzumo Kanesaka, Anurag Kumar Bari, Saïd Abdellati, et al.
Pharmaceutics|July 27, 2024
Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX DeliveryRohit Kumar, Anurag Kumar, Dharmendra Kumar, et al.
Pageof 30

Showing results (241-250 of 300) with videos related to

Sort By:
Pageof 30
Molecular Biology Reports|June 28, 2023
Development and validation of most efficient RNA isolation method from buffalo bull spermatozoaRashi Vasisth, Ankita Gurao, Namita Kumari, et al.
Mini Reviews in Medicinal Chemistry|December 3, 2021
A Comprehensive Review on PCSK9 as Mechanistic Target Approach in Cancer TherapyAmita Singh, Pranesh Kumar, Archana Bharti Sonkar, et al.
Parasites & Vectors|December 5, 2024
Monitoring alpha-cypermethrin susceptibility of Phlebotomus argentipes, the vector of visceral leishmaniasis in India, using the CDC bottle bioassayRahul Chaubey, Ashish Shukla, Anurag Kumar Kushwaha, et al.
Functional & Integrative Genomics|December 26, 2025
Genome Editing Enhanced Abiotic Stress ToleranceIn Cereal CropsShambhu Krishan Lal, Gullnaj Khatoon, Anurag Kumar, et al.
International Journal of Biological Macromolecules|February 17, 2020
Tyr320 is a molecular determinant of the catalytic activity of β-glucosidase from Neosartorya fischeriRamasamy Shanmugam, In-Won Kim, Manish K Tiwari, et al.
AACE Endocrinology and Diabetes|April 6, 2026
Uncovering the Predictors of Nonadherence to Insulin Therapy Among Patients With Type 1 and Type 2 Diabetes Attending an Endocrinology Outpatient Clinic of a Tertiary Care HospitalSourav Debnath, Sanjeet Purohit, Anurag Kumar Singh, et al.
Pharmaceutics|May 4, 2026
Correction: Kumar et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. <i>Pharmaceutics</i> 2024, <i>16</i>, 913Rohit Kumar, Anurag Kumar, Dharmendra Kumar, et al.
Frontiers in Oncology|February 13, 2026
Correction: Epidemiological profile of patients with malignant neoplasm admitted to a tertiary care center in India: a retrospective cross-sectional studySourav Debnath, Pusparghya Pal, Anurag Kumar Singh, et al.
Msystems|January 8, 2026
Characterizing ceftriaxone tolerance in <i>Neisseria gonorrhoeae</i> across <i>in vitro</i> and <i>in vivo</i> modelsIzumo Kanesaka, Anurag Kumar Bari, Saïd Abdellati, et al.
Pharmaceutics|July 27, 2024
Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX DeliveryRohit Kumar, Anurag Kumar, Dharmendra Kumar, et al.
Pageof 30